720MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced gynecological cancers (Gynecol C): Results from a phase I study
Authors
Jian Shu,
Ting ZhuYunchao Huang,
Qinghua Xu,
Ruixia Guo,
Huiping Liu,
Hui Zhao,
Lizhi Zhu,
Xiaolin Wang,
Xiaohong Xu,
Wen Cheng,
Jie Tang,
Qian Zhu,
Xi Chen,
Rui An,
Jie Gao,
Guoqiang Li,
Zhiyong Zhang,
Huaqiang Zhou,
Qi Zhou +18 authors
,
Jiwu Shu Tip Tip